| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 55 | 2024 | 719 | 7.940 |
Why?
|
| Diabetes Mellitus, Type 2 | 60 | 2024 | 1417 | 7.870 |
Why?
|
| Blood Glucose | 38 | 2024 | 1255 | 3.660 |
Why?
|
| Insulin | 38 | 2023 | 1426 | 3.100 |
Why?
|
| Obesity | 35 | 2024 | 2900 | 3.060 |
Why?
|
| Insulin-Secreting Cells | 18 | 2020 | 160 | 2.480 |
Why?
|
| Pediatric Obesity | 11 | 2022 | 375 | 2.470 |
Why?
|
| Overweight | 12 | 2019 | 484 | 2.450 |
Why?
|
| Prediabetic State | 10 | 2024 | 64 | 2.450 |
Why?
|
| Adiposity | 10 | 2023 | 238 | 2.340 |
Why?
|
| Diabetes Mellitus, Type 1 | 13 | 2023 | 856 | 2.090 |
Why?
|
| Metformin | 14 | 2023 | 397 | 1.740 |
Why?
|
| Glucose Tolerance Test | 19 | 2020 | 213 | 1.620 |
Why?
|
| Hypoglycemic Agents | 12 | 2023 | 601 | 1.610 |
Why?
|
| Adolescent | 91 | 2024 | 32784 | 1.440 |
Why?
|
| Cardiorespiratory Fitness | 2 | 2022 | 20 | 1.370 |
Why?
|
| Adipose Tissue | 13 | 2021 | 706 | 1.250 |
Why?
|
| Body Composition | 14 | 2023 | 602 | 1.240 |
Why?
|
| Body Mass Index | 22 | 2023 | 2233 | 1.190 |
Why?
|
| Vascular Stiffness | 5 | 2022 | 79 | 1.100 |
Why?
|
| Metabolic Syndrome | 7 | 2021 | 367 | 1.050 |
Why?
|
| Glucose Clamp Technique | 18 | 2021 | 83 | 1.050 |
Why?
|
| Glucose | 7 | 2023 | 1209 | 0.970 |
Why?
|
| Glucose Intolerance | 8 | 2018 | 85 | 0.960 |
Why?
|
| Hyperglycemia | 4 | 2023 | 337 | 0.950 |
Why?
|
| Endothelium, Vascular | 3 | 2019 | 862 | 0.900 |
Why?
|
| C-Peptide | 9 | 2021 | 126 | 0.900 |
Why?
|
| Child | 65 | 2024 | 30596 | 0.900 |
Why?
|
| Obesity, Abdominal | 2 | 2012 | 44 | 0.810 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 2 | 2020 | 74 | 0.800 |
Why?
|
| Bariatric Surgery | 1 | 2023 | 122 | 0.790 |
Why?
|
| Cardiovascular Diseases | 9 | 2020 | 2221 | 0.780 |
Why?
|
| Vitamin D Deficiency | 3 | 2019 | 122 | 0.760 |
Why?
|
| Vitamin D | 3 | 2019 | 262 | 0.760 |
Why?
|
| Obesity, Morbid | 1 | 2023 | 234 | 0.730 |
Why?
|
| Biomarkers | 13 | 2024 | 5054 | 0.700 |
Why?
|
| Albuminuria | 2 | 2023 | 110 | 0.690 |
Why?
|
| Liraglutide | 1 | 2019 | 16 | 0.670 |
Why?
|
| Atherosclerosis | 3 | 2016 | 908 | 0.670 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2023 | 444 | 0.670 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2019 | 64 | 0.670 |
Why?
|
| Abdominal Fat | 8 | 2012 | 20 | 0.610 |
Why?
|
| Male | 81 | 2024 | 128484 | 0.610 |
Why?
|
| Drug Approval | 1 | 2019 | 176 | 0.610 |
Why?
|
| Registries | 7 | 2020 | 2221 | 0.600 |
Why?
|
| Humans | 108 | 2024 | 271093 | 0.600 |
Why?
|
| Female | 84 | 2024 | 149120 | 0.590 |
Why?
|
| Kidney Diseases | 1 | 2023 | 681 | 0.590 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2018 | 73 | 0.550 |
Why?
|
| Health Status Disparities | 2 | 2016 | 322 | 0.550 |
Why?
|
| Adiponectin | 8 | 2019 | 142 | 0.540 |
Why?
|
| Sleep | 4 | 2024 | 444 | 0.530 |
Why?
|
| Endothelium | 1 | 2016 | 154 | 0.520 |
Why?
|
| Pericardium | 1 | 2016 | 147 | 0.510 |
Why?
|
| Pulse Wave Analysis | 6 | 2023 | 49 | 0.510 |
Why?
|
| Cross-Sectional Studies | 10 | 2022 | 4503 | 0.510 |
Why?
|
| Peptide Hormones | 2 | 2006 | 71 | 0.490 |
Why?
|
| Heart Ventricles | 3 | 2018 | 835 | 0.490 |
Why?
|
| Hyperinsulinism | 4 | 2013 | 85 | 0.480 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2015 | 51 | 0.480 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 559 | 0.450 |
Why?
|
| Fetal Development | 1 | 2015 | 118 | 0.450 |
Why?
|
| Incretins | 4 | 2019 | 28 | 0.440 |
Why?
|
| Risk Factors | 24 | 2024 | 17911 | 0.430 |
Why?
|
| Creatinine | 1 | 2015 | 525 | 0.430 |
Why?
|
| Resistance Training | 1 | 2012 | 39 | 0.400 |
Why?
|
| Absorptiometry, Photon | 7 | 2022 | 234 | 0.390 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2005 | 659 | 0.390 |
Why?
|
| Body Weight | 4 | 2016 | 1289 | 0.390 |
Why?
|
| Autoantibodies | 6 | 2021 | 605 | 0.380 |
Why?
|
| Calcinosis | 1 | 2014 | 426 | 0.370 |
Why?
|
| Triglycerides | 4 | 2023 | 610 | 0.360 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 262 | 0.360 |
Why?
|
| Young Adult | 23 | 2024 | 22293 | 0.350 |
Why?
|
| Amino Acids | 3 | 2024 | 746 | 0.350 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2021 | 154 | 0.350 |
Why?
|
| Diabetic Angiopathies | 4 | 2020 | 75 | 0.340 |
Why?
|
| Exercise | 2 | 2020 | 1209 | 0.340 |
Why?
|
| Diabetic Neuropathies | 1 | 2020 | 93 | 0.320 |
Why?
|
| Lipolysis | 2 | 2021 | 101 | 0.320 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 473 | 0.320 |
Why?
|
| Fasting | 7 | 2020 | 334 | 0.310 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 884 | 0.290 |
Why?
|
| Peptide YY | 1 | 2006 | 21 | 0.270 |
Why?
|
| Dyslipidemias | 5 | 2021 | 241 | 0.270 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2016 | 83 | 0.250 |
Why?
|
| Heart Rate | 3 | 2023 | 744 | 0.240 |
Why?
|
| Intra-Abdominal Fat | 2 | 2021 | 94 | 0.240 |
Why?
|
| Circadian Rhythm | 2 | 2024 | 331 | 0.240 |
Why?
|
| Prehypertension | 2 | 2016 | 13 | 0.240 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 2051 | 0.230 |
Why?
|
| Diabetes Complications | 3 | 2024 | 307 | 0.230 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2024 | 89 | 0.220 |
Why?
|
| Thiazoles | 2 | 2016 | 727 | 0.220 |
Why?
|
| Alanine Transaminase | 1 | 2023 | 238 | 0.210 |
Why?
|
| Gene-Environment Interaction | 1 | 2023 | 163 | 0.210 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2020 | 73 | 0.210 |
Why?
|
| Adult | 18 | 2024 | 82174 | 0.210 |
Why?
|
| Liver | 1 | 2012 | 3063 | 0.200 |
Why?
|
| Obesity, Metabolically Benign | 1 | 2021 | 4 | 0.200 |
Why?
|
| Glutamic Acid | 1 | 2024 | 335 | 0.200 |
Why?
|
| Glomerular Filtration Rate | 2 | 2023 | 588 | 0.200 |
Why?
|
| Glutamine | 1 | 2024 | 325 | 0.200 |
Why?
|
| Melatonin | 1 | 2022 | 53 | 0.200 |
Why?
|
| Prevalence | 8 | 2020 | 3412 | 0.200 |
Why?
|
| Pennsylvania | 4 | 2017 | 68 | 0.190 |
Why?
|
| Pasteurella Infections | 1 | 2001 | 10 | 0.190 |
Why?
|
| Pasteurella multocida | 1 | 2001 | 11 | 0.190 |
Why?
|
| Puberty | 1 | 2021 | 99 | 0.190 |
Why?
|
| Muscular Dystrophies | 1 | 2001 | 62 | 0.180 |
Why?
|
| Basal Metabolism | 1 | 2020 | 86 | 0.180 |
Why?
|
| Diastole | 2 | 2022 | 183 | 0.180 |
Why?
|
| Regression Analysis | 5 | 2006 | 1567 | 0.180 |
Why?
|
| Wearable Electronic Devices | 1 | 2022 | 115 | 0.180 |
Why?
|
| Hypoglycemia | 3 | 2018 | 220 | 0.180 |
Why?
|
| Cohort Studies | 8 | 2020 | 9479 | 0.180 |
Why?
|
| Energy Intake | 1 | 2023 | 517 | 0.180 |
Why?
|
| United States | 10 | 2020 | 15891 | 0.170 |
Why?
|
| Self Report | 1 | 2024 | 798 | 0.170 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 556 | 0.170 |
Why?
|
| Prospective Studies | 4 | 2023 | 13445 | 0.170 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2019 | 18 | 0.170 |
Why?
|
| Weight Loss | 1 | 2023 | 628 | 0.170 |
Why?
|
| Hyperemia | 1 | 2019 | 35 | 0.170 |
Why?
|
| Diabetic Nephropathies | 2 | 2020 | 175 | 0.170 |
Why?
|
| Bone Density | 1 | 2022 | 467 | 0.160 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2019 | 70 | 0.160 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 697 | 0.160 |
Why?
|
| Ideal Body Weight | 1 | 2018 | 8 | 0.160 |
Why?
|
| Minority Groups | 2 | 2018 | 326 | 0.160 |
Why?
|
| Nutrition Surveys | 2 | 2017 | 316 | 0.160 |
Why?
|
| Treatment Failure | 2 | 2019 | 1430 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2018 | 1303 | 0.150 |
Why?
|
| Public Health | 1 | 2020 | 296 | 0.150 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 323 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 1571 | 0.150 |
Why?
|
| Viscera | 3 | 2008 | 88 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 564 | 0.140 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2016 | 7 | 0.140 |
Why?
|
| Calcifediol | 1 | 2016 | 17 | 0.140 |
Why?
|
| Age of Onset | 4 | 2020 | 853 | 0.140 |
Why?
|
| Prognosis | 4 | 2023 | 22529 | 0.130 |
Why?
|
| Child, Preschool | 3 | 2023 | 17095 | 0.130 |
Why?
|
| Systole | 1 | 2016 | 217 | 0.130 |
Why?
|
| Pregnancy in Diabetics | 1 | 2015 | 28 | 0.130 |
Why?
|
| Reference Values | 3 | 2008 | 1129 | 0.130 |
Why?
|
| Risk | 2 | 2017 | 1937 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 502 | 0.130 |
Why?
|
| Proteins | 1 | 2004 | 2029 | 0.130 |
Why?
|
| Ghrelin | 2 | 2006 | 69 | 0.130 |
Why?
|
| Hypertension | 3 | 2021 | 1588 | 0.120 |
Why?
|
| Seasons | 1 | 2016 | 338 | 0.120 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 2346 | 0.120 |
Why?
|
| Abnormalities, Multiple | 1 | 2001 | 1023 | 0.120 |
Why?
|
| Blood Pressure | 5 | 2011 | 1557 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2020 | 988 | 0.120 |
Why?
|
| Texas | 2 | 2016 | 6452 | 0.120 |
Why?
|
| Pneumonia | 1 | 2001 | 794 | 0.120 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2014 | 16 | 0.120 |
Why?
|
| Lipids | 1 | 2018 | 650 | 0.110 |
Why?
|
| Albumins | 1 | 2015 | 263 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 6240 | 0.100 |
Why?
|
| Pregnancy | 3 | 2015 | 8131 | 0.100 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 15282 | 0.100 |
Why?
|
| Meals | 1 | 2013 | 63 | 0.100 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 122 | 0.100 |
Why?
|
| Islets of Langerhans | 2 | 2021 | 235 | 0.100 |
Why?
|
| Mass Screening | 2 | 2018 | 1554 | 0.100 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 684 | 0.100 |
Why?
|
| Patient Dropouts | 1 | 2012 | 84 | 0.100 |
Why?
|
| Heart Atria | 1 | 2014 | 346 | 0.090 |
Why?
|
| Patient Selection | 1 | 2018 | 2032 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2016 | 1823 | 0.090 |
Why?
|
| Life Style | 3 | 2016 | 617 | 0.090 |
Why?
|
| Random Allocation | 1 | 2012 | 731 | 0.090 |
Why?
|
| Drug Combinations | 2 | 2016 | 632 | 0.090 |
Why?
|
| Child Behavior | 1 | 2012 | 247 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2012 | 248 | 0.090 |
Why?
|
| Adolescent Behavior | 1 | 2012 | 237 | 0.090 |
Why?
|
| Lipoproteins, HDL | 2 | 2006 | 127 | 0.080 |
Why?
|
| Aging | 1 | 2017 | 1531 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2012 | 436 | 0.080 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2008 | 19 | 0.080 |
Why?
|
| Drug Therapy, Combination | 3 | 2020 | 2348 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 3846 | 0.080 |
Why?
|
| Testosterone | 1 | 2013 | 638 | 0.080 |
Why?
|
| Body Weights and Measures | 1 | 2006 | 52 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2019 | 33808 | 0.070 |
Why?
|
| Abdomen | 1 | 2008 | 347 | 0.070 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2006 | 24 | 0.070 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2006 | 44 | 0.070 |
Why?
|
| Comorbidity | 3 | 2018 | 2394 | 0.070 |
Why?
|
| Waist-Hip Ratio | 1 | 2006 | 57 | 0.070 |
Why?
|
| Physical Fitness | 1 | 2006 | 126 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 1176 | 0.060 |
Why?
|
| Depression | 1 | 2015 | 1735 | 0.060 |
Why?
|
| Leptin | 2 | 2023 | 304 | 0.060 |
Why?
|
| Anthropometry | 1 | 2016 | 262 | 0.060 |
Why?
|
| Estradiol | 1 | 2008 | 828 | 0.060 |
Why?
|
| Pediatrics | 2 | 2018 | 1189 | 0.060 |
Why?
|
| Phenotype | 3 | 2023 | 6503 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 1047 | 0.050 |
Why?
|
| Sample Size | 1 | 2023 | 213 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 177 | 0.050 |
Why?
|
| Time Factors | 3 | 2024 | 12991 | 0.050 |
Why?
|
| ROC Curve | 3 | 2015 | 1252 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2020 | 9039 | 0.050 |
Why?
|
| Actigraphy | 1 | 2022 | 55 | 0.050 |
Why?
|
| Disease Progression | 3 | 2018 | 6868 | 0.050 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2021 | 41 | 0.050 |
Why?
|
| Hair | 1 | 2001 | 39 | 0.050 |
Why?
|
| Mouth Abnormalities | 1 | 2001 | 16 | 0.050 |
Why?
|
| Ear | 1 | 2001 | 39 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2023 | 483 | 0.050 |
Why?
|
| Aging, Premature | 1 | 2001 | 39 | 0.050 |
Why?
|
| Toes | 1 | 2001 | 48 | 0.050 |
Why?
|
| Light | 1 | 2022 | 278 | 0.050 |
Why?
|
| Animals, Domestic | 1 | 2001 | 41 | 0.050 |
Why?
|
| Life History Traits | 1 | 2020 | 5 | 0.050 |
Why?
|
| Micrognathism | 1 | 2001 | 68 | 0.050 |
Why?
|
| Behavioral Medicine | 1 | 2020 | 15 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2023 | 4642 | 0.040 |
Why?
|
| Fingers | 1 | 2001 | 130 | 0.040 |
Why?
|
| Nose | 1 | 2001 | 141 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2011 | 7786 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 4392 | 0.040 |
Why?
|
| Echocardiography | 2 | 2018 | 1219 | 0.040 |
Why?
|
| Saliva | 1 | 2001 | 238 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 130 | 0.040 |
Why?
|
| Cleft Palate | 1 | 2001 | 148 | 0.040 |
Why?
|
| Dogs | 1 | 2001 | 1074 | 0.040 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 73 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 209 | 0.040 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2018 | 25 | 0.040 |
Why?
|
| Adolescent Medicine | 1 | 2018 | 22 | 0.040 |
Why?
|
| Syndrome | 1 | 2001 | 1409 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2023 | 1185 | 0.040 |
Why?
|
| Diabetic Retinopathy | 1 | 2020 | 161 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 6191 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2017 | 58 | 0.040 |
Why?
|
| Diet Therapy | 1 | 2018 | 52 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2018 | 146 | 0.030 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2016 | 22 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 4104 | 0.030 |
Why?
|
| Health Promotion | 1 | 2020 | 511 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 400 | 0.030 |
Why?
|
| Glucagon | 1 | 2016 | 197 | 0.030 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2018 | 164 | 0.030 |
Why?
|
| Austria | 1 | 2015 | 29 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 7900 | 0.030 |
Why?
|
| Gynecology | 1 | 2018 | 235 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2015 | 8709 | 0.030 |
Why?
|
| Germany | 1 | 2015 | 123 | 0.030 |
Why?
|
| Stillbirth | 1 | 2015 | 86 | 0.030 |
Why?
|
| Endocrinology | 1 | 2018 | 155 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2018 | 420 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2018 | 293 | 0.030 |
Why?
|
| Medical Records | 1 | 2016 | 442 | 0.030 |
Why?
|
| E-Selectin | 1 | 2014 | 106 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 576 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 122 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2014 | 28 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2014 | 215 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 2014 | 33 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2021 | 39951 | 0.030 |
Why?
|
| Inflammation | 2 | 2018 | 2492 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 1270 | 0.030 |
Why?
|
| Animals | 2 | 2013 | 61554 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2015 | 350 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 112 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 1172 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2014 | 229 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 260 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2015 | 348 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 321 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 682 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 831 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 90524 | 0.020 |
Why?
|
| Carnitine | 1 | 2012 | 89 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2015 | 678 | 0.020 |
Why?
|
| Research Design | 1 | 2018 | 1570 | 0.020 |
Why?
|
| Age Factors | 1 | 2020 | 5458 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 616 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 824 | 0.020 |
Why?
|
| Glycemic Index | 1 | 2009 | 29 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 2585 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 1095 | 0.020 |
Why?
|
| Immunoassay | 1 | 2009 | 214 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 3197 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 588 | 0.020 |
Why?
|
| Body Size | 1 | 2007 | 68 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2011 | 796 | 0.020 |
Why?
|
| Proinsulin | 1 | 2006 | 14 | 0.020 |
Why?
|
| Infant | 1 | 2001 | 14045 | 0.020 |
Why?
|
| Exercise Test | 1 | 2006 | 309 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2006 | 126 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2006 | 415 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 12535 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 4966 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 1435 | 0.010 |
Why?
|
| Family | 1 | 2005 | 781 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 4838 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 5165 | 0.010 |
Why?
|
| Diet | 1 | 2005 | 1473 | 0.010 |
Why?
|